Physician profile
Bryan Riley
NPI 1932295201
$2,570.85
in general payments reported to CMS, 2019-2025
8 companies · $40.88 in 2025
The $40.88 reported for 2025 was less than what a typical Surgical provider received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $86.47 · 2022: $1,363 · 2023: $864 · 2024: $217 · 2025: $40.88.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $648 · Food and Beverage: $473.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $648.36 |
| Food and Beverage | $473.23 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Terumo Cardiovascular Systems Corporation | $1,995.32 | 2022-2023 | Harvest, Virtuosaph Plus With Radial Indication |
| Medtronic, INC. | $181.33 | 2021-2024 | Penditure, Trillium Affinity Nt, Penditure |
| Lsi Solutions INC | $175.38 | 2023-2025 | Cor-Knot, Cor Knot |
| Baxter Healthcare | $63.89 | 2024 | Preveleak |
| Astrazeneca Pharmaceuticals LP | $58.70 | 2021 | |
| Abiomed | $36.02 | 2022 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $34.27 | 2024 | Lifevest |
| Atricure, INC. | $25.94 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bryan Riley listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.